Post-approval variations to dossiers for vaccines: analysis of regulatory and methodological approaches used in the Russian Federation and abroad

The management of post-approval changes to registration dossiers for medicinal products is one of the most important factors for ensuring sustainable quality, safety and efficacy of medicines. Competent authorities that use the module format of the registration dossier, i.e. the regulatory authoriti...

Full description

Saved in:
Bibliographic Details
Main Authors: V. A. Shevtsov, Yu. V. Olefir, V. A. Merkulov, V. P. Bondarev, I. N. Indikova, E. E. Evreinova, A. V. Rukavishnikov, L. M. Khantimirova, D. V. Gorenkov
Format: Article
Language:Russian
Published: Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) 2019-03-01
Series:Регуляторные исследования и экспертиза лекарственных средств
Subjects:
Online Access:https://www.vedomostincesmp.ru/jour/article/view/171
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839583217214029824
author V. A. Shevtsov
Yu. V. Olefir
V. A. Merkulov
V. P. Bondarev
I. N. Indikova
E. E. Evreinova
A. V. Rukavishnikov
L. M. Khantimirova
D. V. Gorenkov
author_facet V. A. Shevtsov
Yu. V. Olefir
V. A. Merkulov
V. P. Bondarev
I. N. Indikova
E. E. Evreinova
A. V. Rukavishnikov
L. M. Khantimirova
D. V. Gorenkov
author_sort V. A. Shevtsov
collection DOAJ
description The management of post-approval changes to registration dossiers for medicinal products is one of the most important factors for ensuring sustainable quality, safety and efficacy of medicines. Competent authorities that use the module format of the registration dossier, i.e. the regulatory authorities of the European Union, USA and other members of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), and the Eurasian Economic Union (EEU), issue guidelines on changes to registration dossiers for pharmaceuticals and biologicals (immunological products). Vaccines (finished dosage forms) and vaccine antigens (active ingredients) are a specific group of immunobiological products which have great prophylactic importance for healthcare, and which are associated with challenging development and specific methods of manufacturing and quality control. The procedure of introducing post-approval variations to dossiers for immunobiological medicinal products is poorly reflected in the current Russian and EEU regulations. The World Health Organization (WHO) established a procedure described in the «Guidelines on procedures and data requirements for changes to approved vaccines». The purpose of the present study was to compare current Russian and international legislation in terms of regulatory requirements for post-approval сhanges to dossiers for immunobiological products. The Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation is drafting Guideline on introducing post-approval changes into dossiers for immunobiological medicines. The draft includes a detailed review of various categories of changes based on their importance, and a list of conditions and required documents for specific groups of medicines. This article summarises scientific and methodological approaches to evaluation of changes introduced in registration dossiers for vaccines in order to further improve the regulatory framework of the Russian Federation and the EEU.
format Article
id doaj-art-f174a2d0d0d24a6da0c6fbc8e67b4f84
institution Matheson Library
issn 3034-3062
3034-3453
language Russian
publishDate 2019-03-01
publisher Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
record_format Article
series Регуляторные исследования и экспертиза лекарственных средств
spelling doaj-art-f174a2d0d0d24a6da0c6fbc8e67b4f842025-08-03T19:56:43ZrusFederal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)Регуляторные исследования и экспертиза лекарственных средств3034-30623034-34532019-03-0191414810.30895/1991-2919-2019-9-1-41-48188Post-approval variations to dossiers for vaccines: analysis of regulatory and methodological approaches used in the Russian Federation and abroadV. A. Shevtsov0Yu. V. Olefir1V. A. Merkulov2V. P. Bondarev3I. N. Indikova4E. E. Evreinova5A. V. Rukavishnikov6L. M. Khantimirova7D. V. Gorenkov8Scientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsThe management of post-approval changes to registration dossiers for medicinal products is one of the most important factors for ensuring sustainable quality, safety and efficacy of medicines. Competent authorities that use the module format of the registration dossier, i.e. the regulatory authorities of the European Union, USA and other members of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), and the Eurasian Economic Union (EEU), issue guidelines on changes to registration dossiers for pharmaceuticals and biologicals (immunological products). Vaccines (finished dosage forms) and vaccine antigens (active ingredients) are a specific group of immunobiological products which have great prophylactic importance for healthcare, and which are associated with challenging development and specific methods of manufacturing and quality control. The procedure of introducing post-approval variations to dossiers for immunobiological medicinal products is poorly reflected in the current Russian and EEU regulations. The World Health Organization (WHO) established a procedure described in the «Guidelines on procedures and data requirements for changes to approved vaccines». The purpose of the present study was to compare current Russian and international legislation in terms of regulatory requirements for post-approval сhanges to dossiers for immunobiological products. The Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation is drafting Guideline on introducing post-approval changes into dossiers for immunobiological medicines. The draft includes a detailed review of various categories of changes based on their importance, and a list of conditions and required documents for specific groups of medicines. This article summarises scientific and methodological approaches to evaluation of changes introduced in registration dossiers for vaccines in order to further improve the regulatory framework of the Russian Federation and the EEU.https://www.vedomostincesmp.ru/jour/article/view/171quality evaluationquality standardschangesvariationsregistration dossiermaster-filevaccine antigenvaccine
spellingShingle V. A. Shevtsov
Yu. V. Olefir
V. A. Merkulov
V. P. Bondarev
I. N. Indikova
E. E. Evreinova
A. V. Rukavishnikov
L. M. Khantimirova
D. V. Gorenkov
Post-approval variations to dossiers for vaccines: analysis of regulatory and methodological approaches used in the Russian Federation and abroad
Регуляторные исследования и экспертиза лекарственных средств
quality evaluation
quality standards
changes
variations
registration dossier
master-file
vaccine antigen
vaccine
title Post-approval variations to dossiers for vaccines: analysis of regulatory and methodological approaches used in the Russian Federation and abroad
title_full Post-approval variations to dossiers for vaccines: analysis of regulatory and methodological approaches used in the Russian Federation and abroad
title_fullStr Post-approval variations to dossiers for vaccines: analysis of regulatory and methodological approaches used in the Russian Federation and abroad
title_full_unstemmed Post-approval variations to dossiers for vaccines: analysis of regulatory and methodological approaches used in the Russian Federation and abroad
title_short Post-approval variations to dossiers for vaccines: analysis of regulatory and methodological approaches used in the Russian Federation and abroad
title_sort post approval variations to dossiers for vaccines analysis of regulatory and methodological approaches used in the russian federation and abroad
topic quality evaluation
quality standards
changes
variations
registration dossier
master-file
vaccine antigen
vaccine
url https://www.vedomostincesmp.ru/jour/article/view/171
work_keys_str_mv AT vashevtsov postapprovalvariationstodossiersforvaccinesanalysisofregulatoryandmethodologicalapproachesusedintherussianfederationandabroad
AT yuvolefir postapprovalvariationstodossiersforvaccinesanalysisofregulatoryandmethodologicalapproachesusedintherussianfederationandabroad
AT vamerkulov postapprovalvariationstodossiersforvaccinesanalysisofregulatoryandmethodologicalapproachesusedintherussianfederationandabroad
AT vpbondarev postapprovalvariationstodossiersforvaccinesanalysisofregulatoryandmethodologicalapproachesusedintherussianfederationandabroad
AT inindikova postapprovalvariationstodossiersforvaccinesanalysisofregulatoryandmethodologicalapproachesusedintherussianfederationandabroad
AT eeevreinova postapprovalvariationstodossiersforvaccinesanalysisofregulatoryandmethodologicalapproachesusedintherussianfederationandabroad
AT avrukavishnikov postapprovalvariationstodossiersforvaccinesanalysisofregulatoryandmethodologicalapproachesusedintherussianfederationandabroad
AT lmkhantimirova postapprovalvariationstodossiersforvaccinesanalysisofregulatoryandmethodologicalapproachesusedintherussianfederationandabroad
AT dvgorenkov postapprovalvariationstodossiersforvaccinesanalysisofregulatoryandmethodologicalapproachesusedintherussianfederationandabroad